DNA X, Inc. SONM
$2.99
-$0.03-0.99%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 16.21M | 27.40M | 44.13M | 59.11M | 57.92M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.21M | 27.40M | 44.13M | 59.11M | 57.92M |
| Cost of Revenue | 14.40M | 14.40M | 14.40M | 14.40M | 10.79M |
| Gross Profit | 1.82M | 1.82M | 1.82M | 1.82M | 4.23M |
| SG&A Expenses | 7.96M | 8.15M | 5.41M | -5.64M | -5.36M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.96M | 8.15M | 5.41M | -29.21M | -32.01M |
| Operating Income | -7.96M | -8.15M | -5.41M | 2.11M | 3.72M |
| Income Before Tax | -10.30M | -10.92M | -7.96M | 1.39M | 3.66M |
| Income Tax Expenses | 90.00K | 90.00K | 90.00K | 90.00K | 117.00K |
| Earnings from Continuing Operations | -10.30 | -10.92 | -7.96 | 1.58 | 3.82 |
| Earnings from Discontinued Operations | 1.75M | -3.85M | -12.70M | -4.20M | -4.20M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.55M | -14.78M | -20.66M | -33.38M | -31.14M |
| EBIT | -7.96M | -8.15M | -5.41M | 2.11M | 3.72M |
| EBITDA | -4.37M | -3.83M | -1.11M | 5.83M | 7.40M |
| EPS Basic | -10.12 | -23.34 | -26.94 | -99.43 | -103.93 |
| Normalized Basic EPS | -4.16 | -5.69 | -5.61 | 14.50 | 11.91 |
| EPS Diluted | -10.12 | -23.34 | -26.94 | -99.43 | -103.93 |
| Normalized Diluted EPS | -4.16 | -5.69 | -5.61 | 14.50 | 11.91 |
| Average Basic Shares Outstanding | 4.32M | 3.50M | 2.56M | 2.10M | 1.38M |
| Average Diluted Shares Outstanding | 4.32M | 3.50M | 2.56M | 2.10M | 1.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |